Elgethun Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.86M | Sell |
14,495
-182
| -1% | -$21.3K | 0.26% | 49 |
|
|
2026
Q1 | $1.77M | Buy |
14,677
+2,776
| +23% | +$320K | 0.29% | 47 |
|
|
2025
Q4 | $1.25M | Buy |
11,901
+35
| +0.3% | +$3.29K | 0.22% | 55 |
|
|
2025
Q3 | $1.03M | Sell |
11,866
-113
| -0.9% | -$9.31K | 0.19% | 59 |
|
|
2025
Q2 | $948K | Buy |
11,979
+41
| +0.3% | +$3.26K | 0.19% | 55 |
|
|
2025
Q1 | $1.07M | Sell |
11,938
-167
| -1% | -$15.6K | 0.24% | 52 |
|
|
2024
Q4 | $1.2M | Buy |
12,105
+49
| +0.4% | +$5.05K | 0.29% | 48 |
|
|
2024
Q3 | $1.37M | Sell |
12,056
-78
| -0.6% | -$9.27K | 0.32% | 46 |
|
|
2024
Q2 | $1.5M | Sell |
12,134
-76
| -0.6% | -$9.79K | 0.38% | 48 |
|
|
2024
Q1 | $1.59M | Buy |
12,210
+5,224
| +75% | +$644K | 0.4% | 46 |
|
|
2023
Q4 | $762K | Sell |
6,986
-98
| -1% | -$10.2K | 0.22% | 61 |
|
|
2023
Q3 | $727K | Buy |
7,084
+4,355
| +160% | +$469K | 0.22% | 62 |
|
|
2023
Q2 | $315K | Buy |
2,729
+12
| +0.4% | +$1.36K | 0.09% | 90 |
|
|
2023
Q1 | $291K | Buy |
2,717
+13
| +0.5% | +$1.4K | 0.09% | 94 |
|
|
2022
Q4 | $298K | Buy |
2,704
+42
| +2% | +$4.29K | 0.11% | 87 |
|
|
2022
Q3 | $229K | Sell |
2,662
-37,744
| -93% | -$3.37M | 0.09% | 98 |
|
|
2022
Q2 | $3.69M | Sell |
40,406
-534
| -1% | -$47.3K | 1.43% | 23 |
|
|
2022
Q1 | $3.36M | Buy |
40,940
+445
| +1% | +$35.1K | 1.14% | 28 |
|
|
2021
Q4 | $3.1M | Sell |
40,495
-2,228
| -5% | -$177K | 1.08% | 31 |
|
|
2021
Q3 | $3.21M | Sell |
42,723
-791
| -2% | -$60.2K | 1.11% | 31 |
|
|
2021
Q2 | $3.38M | Buy |
43,514
+33,341
| +328% | +$2.48M | 1.16% | 28 |
|
|
2021
Q1 | $748K | Buy |
10,173
+1,357
| +15% | +$100K | 0.29% | 51 |
|
|
2020
Q4 | $688K | Buy |
8,816
+1,014
| +13% | +$77.6K | 0.29% | 52 |
|
|
2020
Q3 | $615K | Hold |
7,802
| – | – | 0.34% | 47 |
|
|
2020
Q2 | $511K | Buy |
7,802
+73
| +0.9% | +$5.5K | 0.3% | 48 |
|
|
2020
Q1 | $567K | Sell |
7,729
-1,997
| -21% | -$157K | 0.32% | 52 |
|
|
2019
Q4 | $844K | Sell |
9,726
-21
| -0.2% | -$1.73K | 0.41% | 42 |
|
|
2019
Q3 | $783K | Buy |
9,747
+681
| +8% | +$54.6K | 0.42% | 45 |
|
|
2019
Q2 | $725K | Hold |
9,066
| – | – | 0.4% | 50 |
|
|
2019
Q1 | $720K | Buy |
9,066
+52
| +0.6% | +$3.89K | 0.42% | 53 |
|
|
2018
Q4 | $652K | Sell |
9,014
-530
| -6% | -$37.4K | 0.45% | 55 |
|
|
2018
Q3 | $650K | Hold |
9,544
| – | – | 0.42% | 56 |
|
|
2018
Q2 | $550K | Buy |
9,544
+419
| +5% | +$23.6K | 0.39% | 63 |
|
|
2018
Q1 | $474K | Buy |
9,125
+846
| +10% | +$45.7K | 0.33% | 71 |
|
|
2017
Q4 | $445K | Sell |
8,279
-57
| -0.7% | -$3.16K | 0.31% | 67 |
|
|
2017
Q3 | $509K | Hold |
8,336
| – | – | 0.37% | 58 |
|
|
2017
Q2 | $510K | Sell |
8,336
-137
| -2% | -$8.34K | 0.4% | 55 |
|
|
2017
Q1 | $514K | Hold |
8,473
| – | – | 0.41% | 52 |
|
|
2016
Q4 | $476K | Buy |
+8,473
| New | +$496K | 0.37% | 52 |
|
Other funds holding MRK
ECSS
ATO
Elgethun Capital Management's MRK Position: Q2 2026 in Review
Elgethun Capital Management reduced its Merck (MRK) stake by 1.2% in Q2 2026, selling an estimated $21.3K and leaving 14,495 shares worth $1.86M. The position accounts for 0.26% of the portfolio, ranked #49.
Elgethun Capital Management first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.69M in Q2 2022. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Elgethun Capital Management held 14,495 shares of Merck worth $1.86M as of Q2 2026.
- Elgethun Capital Management sold 182 Merck shares in Q2 2026, an estimated $21.3K.
- Merck made up 0.26% of Elgethun Capital Management's portfolio in Q2 2026, its #49 holding.
- Elgethun Capital Management first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Elgethun Capital Management's Merck position peaked at $3.69M in Q2 2022.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Elgethun Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.